Form 4: Arteris Director Saiyed Atiq Raza Files Future Stock Sale Under 10b5-1 Plan

Arteris, Inc. Director Saiyed Atiq Raza has filed a Form 4 indicating a pre-planned sale of 19,809 shares of common stock on June 27, 2025, at a weighted average price of $10.0203 per share, executed under a Rule 10b5-1 trading plan.

Summary

• Arteris, Inc. Director Saiyed Atiq Raza reported a planned disposition of 19,809 shares of common stock.
• The transaction is scheduled for June 27, 2025.
• The shares were sold at a weighted average price of $10.0203 per share, with prices ranging from $10.00 to $10.10.
• The sale is being conducted pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2024.
• Following the transaction, Saiyed Atiq Raza will beneficially own 20,839 shares directly and 683,798 shares indirectly through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which the Reporting Person serves as trustee.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an insider sale can be perceived negatively, the fact that it's a pre-planned transaction under a 10b5-1 plan and represents a relatively small portion of the director's total holdings mitigates significant negative sentiment. It suggests a planned financial move rather than a reaction to adverse company news.

Positives

• The transaction is executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled and non-discretionary sale, which often mitigates concerns about insider selling.

Negatives

• A director selling shares, even if pre-planned, can sometimes be perceived as a lack of confidence in the company's near-term prospects, though this is a relatively small portion of the director's total holdings.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing pertains to an individual insider transaction and does not provide broader industry context or trends. It is a routine disclosure for a director's stock activity.

Stakeholder Impact

• Shareholders: The sale of a relatively small number of shares by a director under a pre-planned arrangement is unlikely to have a significant direct impact on the company's share price or investor confidence, but it is a data point for those tracking insider activity.

Key Dates

Keywords

Arteris, AIP, Form 4, Insider Sale, Stock Transaction, Beneficial Ownership, Saiyed Atiq Raza, 10b5-1 Plan, Director